Expression of growth factors in normal and neoplastic pituitary tissues

Endocrine Pathology

Volumn 11, Issue 4, 2000, Pages 295-300

  Saeger, Wolfgang ^a  

^a Institute of Pathology of the Marienkrankenhaus Hamburg   (Germany)

Author keywords

Growth factors; Pituitary; Proliferation; Tumorigenesis

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 4; GROWTH FACTOR; NERVE GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN B; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

CANCER GROWTH; CELL PROLIFERATION; GENE EXPRESSION; HUMAN; HYPOPHYSIS; HYPOPHYSIS FUNCTION; HYPOPHYSIS TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW;

EID: 0034443475     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1385/EP:11:4:295     Document Type: Review

References (55)

1. 1. Chaidarun SS, Eggo MC, Sheppard MC, Stewart PM, Expression of epidermal growth factor (EGF), its receptor, and related oncoprotein (erbB-2) in human pituitary tumors and response to EGF in vitro. Endocrinology 135:2012-2021, 1994.
2. 2. Jaffrain-Rea ML, Petrangeli E, Lubrano C, et al. Epidermal growth factor binding sites in human pituitary macroadenomas. J Endocrinol 158:425-433, 1998.
3. 3. Kontogeorgos G, Stefaneanu L, Kovacs K, Cheng Z. Localization of epidermal growth factor (EGF) and epidermal growth factor receptor (EGFr) in human pituitary adenomas and nontumorous pituitaries: An immunocytochemical study. Endocr Pathol 7:63-70, 1996.
4. 4. Krämer A, Saeger W, Tallen G, Lüdecke DK. DNA measurement, proliferation markers, and other factors in pituitary adenomas. Endocr Pathol 5:198-211, 1994.
5. 5. Lübke D, Saeger W, Lüdecke DK. Proliferation markers and EGF in ACTH-secreting adenomas and carcinomas of the pituitary. Endocr Pathol 6:45-55, 1995.
6. 6. Ren P, Scheithauer BW, Halper J. Immunohistological localization of TGF-alpha, EGF, IGF-I, and TGF-beta in the normal human pituitary gland. Endocr Pathol 5:40-48, 1994.
7. 7. Kajikawa K, Yasui W, Sumiyoshi H, et al. Expression of epidermal growth factor in human tissues. Immunohistochemical and biochemical analysis. Virchows Arch A Pathol Anat Histopath 418:27-32, 1991.
8. 8. Alexander JM, Bikkal HA, Zervas NT, Laws ER, Klibanski A. Tumor-specific expression and alternative splicing of messenger ribonucleic acid encoding activin/transforming growth factor-β receptors in human pituitary adenomas. J Clin Endocrinol Metab. 81:783-790, 1996.
9. 9. Birman P, Michard M, Li JY, Peillon F, Bression D. Epidermal growth factor-binding sites, present in normal human and rat pituitaries, are absent in human pituitary adenomas. J Clin Endocrinol Metab. 65:275-281, 1987.
10. 10. Murdoch GH, Potter E, Nicolaisen AK, Evans RM, Rosenfeld MG. Epidermal growth factor rapidly stimulates prolactin gene transcription. Nature 300:192-194, 1982.
11. 11. Missale C, Castelletti L, Boroni F, Memo M, Spano P. Epidermal growth factor induces the functional expression of dopamine receptors in the GH 3 cell lines. Endocrinology 128:13-20, 1991.
12. 12. Ikeda H, Mitsuhashi T, Kubota K, Kuzuya N, Uchimura H. Epidermal growth factor stimulates growth hormone secretion from super-fused rat adenohypophyseal fragments. Endocrinology 115:556-558, 1984.
13. 13. Ezzat S, Melmed S. The role of growth factors in the pituitary. J Endocrinol Invest 13:691-698, 1990.
14. 14. Le Riche VK, Asa SL, Ezzat S. Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumor aggressiveness. J Clin Endocrinol Metab 81:656-662, 1996.
15. 15. Finley EL, King JS, Ramsdell JS. Human pituitary somatotropes express transforming growth factor-alpha and its receptor. J Endocrinol 141:547-554, 1994.
16. 16. Driman DK, Kobrin MS, Kudlow JE, Asa SL. Transforming growth factor-alpha in normal and neoplastic human endocrine tissues. Hum Pathol 23:1365, 1992.
17. 17. Halper J, Parnell PG, Carter BJ, Ren P, Scheithauer BW. Presence of growth factors in human pituitary. Lab Invest 66:639-645, 1992.
18. 18. Pen G, Scheithauer BW, Halper J. Immunocytochemical localization of TGF-alpha and IGF-1 in human pituitary gland. Mod Pathol 6:41A, 1993.
19. 19. Ezzat S, Walpola IA, Ramyar L, Smyth HS, Asa SL. Membrane-anchored expression of transforming growth factor-alpha in human pituitary adenoma cells. J Clin Endocrinol Metab 80:534-539, 1995.
20. 20. McAndrew J, Paterson AJ, Asa SL, McCarthy KJ, Kudlow JE. Targeting of transforming growth factor-alpha expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas. Endocrinology 136:4479-4488, 1995.
21. 21. Qian X, Jin L, Grande JP, Lloyd RV. Transforming growth factor-beta and p27 expression in pituitary cells. Endocrinology 137: 3051-3060, 1996.
22. 22. Sarkar DK, Kim KH, Minami S. Transforming growth factor-β1 messenger RNA and protein expression in the pituitary gland: its action on prolactin secretion and lactotropic growth. Mol Endocrinol 6:1825, 1992.
23. 23. Ikeda H, Yoshimoto T. Molecular analysis of human pituitary adenoma with special reference to cell-cycle regulatory genes. Canc J 11:132-136, 1998.
24. 24. Fujiwara K, Ikeda H, Yoshimoto T. Immunohistochemical demonstration of transforming growth factor-beta-1 in human pituitary adenomas. Acta Histochem Cytochem 28:333-339, 1995.
25. 25. Fujiwara K, Ikeda H, Yoshimoto T. Immunohistochemical demonstration of TGF-beta-receptor type II in human pituitary adenomas. Acta Histochem 97:445-454, 1995.
26. 26. Thapar K, Kovacs K, Laws ER Jr. The classification and molecular biology of pituitary adenomas. In: Symon L (ed): Advances and technical standards in neurosurgery, Springer, Wien, New York: 1995: 3-53.
27. 27. Yokoyama S, Stefaneanu L, Kovacs K. Pituitary insulin-like growth factors. Endocr Pathol 8:167-179, 1997.
28. 28. Spada A. Growth factors and human pituitary adenomas. Eur J Endocrinol 138:255-257, 1998.
29. 29. Yokoyama S, Thapar K, Kovacs K, Stefaneanu L. Localization of insulin-like growth factor-II mRNA in human pituitary adenomas. Virchows Archiv Path Anat 432:241-246, 1998.
30. 30. Ezzat S, Horvath E, Kovacs K, Smyth HS, Singer W, Asa SL. Basic fibroblast growth factor expression by two prolactin and thyrotropin-producing pituitary adenomas. Endocr Pathol 6:125-134, 1995.
31. 31. Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G. Structural characterization and biological functions of fibroblast growth factor. Endocr Rev 8:95-114, 1987.
32. 32. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13:18-32, 1992.
33. 33. Melmed S. Pathogenesis of pituitary tumors. Endocrinol Metab Clin N Amer 28:1, 1999.
34. 34. Prysor-Jones RA, Silverlight JJ, Jenkins JS. Oestradiol, vasoactive intestinal peptide and fibroblast growth factor in the growth of human pituitary tumor cells in vitro. J Endocrinol 120:171-177, 1989.
35. 35. Asa SL, Ezzat S. The cytogenesis and pathogenesis of pituitary adenomas. Endocrine Rev 19:798-827, 1998.
36. 36. Ezzat S, Smyth HS, Ramyar L, Asa SL. Heterogenous in vivo and in vitro expression of basic fibroblast growth factor by human pituitary adenomas. J Clin Endocrinol Metab. 80:878-884, 1995.
37. 37. Ray D, Melmed S. Pituitary cytokine and growth factor expression and action. Endocr Rev 18:206-228, 1997.
38. 38. Shimon I, Hinton DR, Weiss MH, Melmed S. Prolactinomas express human heparin-binding secretory transforming gene (hst) protein product: marker of tumour invasiveness. Clin Endocrinol (Oxf) 48:23-29, 1998.
39. 39. Shimon I, Hüttner A, Said J, Spirina OM, Melmed S. Heparin-binding secretory transforming gene (hst) facilitates rat lactotrope cell tumorigenesis and induces prolactin gene transcription. J Clin Invest 97:187-195, 1996.
40. 40. Missale C, Spano P. Nerve growth factor in pituitary development and pituitary tumors. Front Neuroendocrinol 19:128-150, 1998.
41. 41. Patterson JC, Childs GV. Nerve growth factor and its receptor in the anterior pituitary. Endocrinology 135:1689-1696, 1994.
42. 42. Missale C, Boroni F, Sigala S, et al. Nerve growth factor in the anterior pituitary: localization in mammotroph cells and cosecretion with prolactin by dopamine-regulated mechanism. Proc Natl Acad Sci USA 93:4240, 1996.
43. 43. Missale C, Boroni F, Losa M, et al. Nerve growth factor suppresses the transformation phenotype of human prolactinomas. Proc Natl Acad Sci USA 90:7961-7965, 1993.
44. 44. Borrelli E, Sawchenko PE, Evans RM. Pituitary hyperplasia induced by ectopic expression of nerve growth factor. Proc Natl Acad Sci USA 89:2764-2768, 1992.
45. 45. Missale C, Boroni F, Sigala S, Zanellato A, Dal Toso R, Balsari A, Spano P. Nerve growth factor directs differentiation of the bipotential cell line GH-3 into the mammotroph pheno-type. Endocrinology 135:290-298, 1994.
46. 46. Nishikawa R, Cheng SY, Nagashima R, Huang HJS, Cavenee WK, Matsutani M. Expression of vascular endothelial growth factor in human brain tumors. Acta Neuropathol 96:453-462, 1998.
47. 47. Vidal S, Kovacs K, Cohen SM, Stefaneanu L, Lloyd RV, Scheithauer BW. Localization of vascular endothelial growth factor in non-tumorous human pituitaries. Endocr Pathol 10:109-122, 1999.
48. 48. Yamamoto T, Nishizawa Y, Tsuji M, et al. Expression of vascular endothelial growth factor in normal pituitary cells and pituitary adenomas producing adrenocorticotropic hormone. Endocr Pathol 10:157-164, 1999.
49. 49. Atchison JA, Lee PA, Albright AL. Reversible suprasellar pituitary mass secondary to hypothyroidism. JAMA 262:3175-3177, 1989.
50. 50. Dorfman HD. Bone diseases. In: Sternberg SS, Antonioli DA, Carter D, Eggleston JC, Mills SE, Oberman HA (eds): Diagnostic surgical pathology. New York: Raven Press, 1989; 217-252.
51. 51. Schreiber S, Saeger W, Lüdecke DK. Proliferation markers in different types of clinically non-secreting pituitary adenomas. Pituitary 1:213-220, 1999.
52. 52. Renner U, Mojto J, Arzt E, et al. Secretion of polypeptide growth factors by human non-functioning pituitary adenoma cells in culture. Neuroendocrinology 57:825-834, 1993.
53. 53. Gambarini AG, Armelin HA. Purification and partial characterisation of an acidic fibroblast growth factor from bovine pituitary. J Biol Chem 257:9692-9697, 1982.
54. 54. Givol D, Yazaki M. Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J 6:3362-3369, 1992.
55. 55. Kasper S, Friesen HG. Human pituitary tissue secretes a potent growth factor for chondrocyte proliferation. J Clin Endocrinol Metab 62:70-76, 1986.